FragGrow: A Web Server for Structure-Based Drug Design by Fragment Growing within Constraints-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FragGrow: A Web Server for Structure-Based Drug Design by Fragment Growing within Constraints

Published:2024-05-10 Issue:10 Volume:64 Page:3970-3976
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Zhang Yueqing¹²,Zhang Zhihan¹²,Ke Dongliang¹²,Pan Xiaolin¹²^ORCID,Wang Xingyu²,Xiao Xudong¹,Ji Changge¹²^ORCID

Affiliation:

1. Shanghai Engineering Research Center of Molecular Therapeutics & New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200062, China

2. NYU−ECNU Center for Computational Chemistry at NYU Shanghai, Shanghai, 200062, China

Funder

East China Normal University

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00154

Reference32 articles.

1. Fragment-to-Lead Medicinal Chemistry Publications in 2020

2. Fragment-to-Lead Medicinal Chemistry Publications in 2021

3. Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers

4. A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA

5. Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridines as Focal Adhesion Kinase Inhibitors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP